If you are an Aetna member and received a letter regarding contract negotiations with NewYork-Presbyterian, you may find out the latest information here.

Locations and Appointments

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Personal Statement

I firmly believe that world-class patient care requires compassion and empathy. My philosophy of medicine is simple: Not only do I strive to provide the most cutting-edge treatments to my patients, but I also make them the centerpiece of medical decision making. The therapeutic landscape of oncology is ever-evolving with novel treatment strategies, targeted and immunotherapies, and precision medicine technology. Therefore, it is so important for physicians to have effective communication with patients and their caregivers in order to determine the best treatment option for each patient’s unique needs. I strive to personalize care of every patient by incorporating the latest clinical research, evidence-based medicine and molecularly-guided treatments. I am also fortunate to be part of Weill Cornell Medicine, where I can offer my patients several clinical trials, giving them early access to novel treatments often years before they are available elsewhere.

Biographical Info

Dr. Uqba Khan is an Assistant Professor of Clinical Medicine within the faculty of Weill Cornell Medical College in the Division of Hematology and Medical Oncology. Dr. Khan is also an Attending Physician at NewYork-Presbyterian Brooklyn Methodist Hospital.      

Dr. Khan received his medical degree from Allama Iqbal Medical College, Pakistan in 2008. He underwent his internal medicine training at St. Agnes Hospital in Baltimore and later completed his hematology/oncology fellowship at St. John Hospital and Medical Center in Detroit, where he also served as chief fellow.      

Dr. Khan has a special interest in treatment of gastrointestinal (GI) malignancies and clinical research. He joined Weill Cornell Medicine in 2018 to complete an additional year of training in management of gastrointestinal malignancies. He also worked as an instructor at Weill Cornell Medical College between 2018 and 2019. In June of 2019, Dr. Khan was promoted to Assistant Professor of Clinical Medicine within the faculty of Weill Cornell Medical College in the Division of Hematology and Medical Oncology.      

Dr. Khan has been involved in a number of clinical and translational research studies. His research focuses on optimizing the effectiveness of immunotherapy in solid malignancies. He has published a number of research articles and is actively involved as an investigator in several clinical trials. He has presented his research findings at several professional conferences and meetings.      

Dr. Khan is a member of several national and international professional societies, including the American Society of Clinical Oncology (ASCO), the Society of Immunotherapy in Cancer (SITC), the European Society of Medical Oncology (ESMO) and the American Association for Cancer Research (AACR).

Honors and Awards

ASCO Conquer Cancer Foundation Merit Award 2019
ASCO Conquer Cancer Foundation Merit Award 2018
Society for Immunotherapy of Cancer Sparkathon 2017
Best Medical Resident 2015

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Gastrointestinal Oncology
Esophageal Cancer
Gastric Cancer
Colorectal Cancer
Pancreatic Cancer
Liver Cancer
Biliary Tract Cancer
Small Bowel Cancer
Anal Cancer
Neuroendocrine Cancer
Gastrointestinal Stromal Tumor (GIST)
Thoracic Cancer
  • M.B.,B.S.
    Allama Iqbal Medical College, University of Punjab (Pakistan)
  • Attending Physician
    NewYork-Presbyterian/Brooklyn Methodist Hospital
  • Assistant Professor of Clinical Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Other Interest: 
Amgen, Inc.